83 related articles for article (PubMed ID: 27041209)
21. Regional activation of the cancer genome by long-range epigenetic remodeling.
Bert SA; Robinson MD; Strbenac D; Statham AL; Song JZ; Hulf T; Sutherland RL; Coolen MW; Stirzaker C; Clark SJ
Cancer Cell; 2013 Jan; 23(1):9-22. PubMed ID: 23245995
[TBL] [Abstract][Full Text] [Related]
22. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.
Guan M; Zhou X; Soulitzis N; Spandidos DA; Popescu NC
Clin Cancer Res; 2006 Mar; 12(5):1412-9. PubMed ID: 16533763
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic CpG Methylation of the Promoter and Reactivation of the Expression of GSTP1 by Astaxanthin in Human Prostate LNCaP Cells.
Yang Y; Fuentes F; Shu L; Wang C; Pung D; Li W; Zhang C; Guo Y; Kong AN
AAPS J; 2017 Mar; 19(2):421-430. PubMed ID: 27913949
[TBL] [Abstract][Full Text] [Related]
24. Transcription Factor HBP1 Enhances Radiosensitivity by Inducing Apoptosis in Prostate Cancer Cell Lines.
Chen Y; Wang Y; Yu Y; Xu L; Zhang Y; Yu S; Li G; Zhang Z
Anal Cell Pathol (Amst); 2016; 2016():7015659. PubMed ID: 26942107
[TBL] [Abstract][Full Text] [Related]
25. Cloning of mouse Dab2ip gene, a novel member of the RasGTPase-activating protein family and characterization of its regulatory region in prostate.
Chen H; Karam JA; Schultz R; Zhang Z; Duncan C; Hsieh JT
DNA Cell Biol; 2006 Apr; 25(4):232-45. PubMed ID: 16629596
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive epigenetic analysis using oral rinse samples: a pilot study.
Kusumoto T; Hamada T; Yamada N; Nagata S; Kanmura Y; Houjou I; Kamikawa Y; Yonezawa S; Sugihara K
J Oral Maxillofac Surg; 2012 Jun; 70(6):1486-94. PubMed ID: 21821326
[TBL] [Abstract][Full Text] [Related]
27. The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.
Ngollo M; Lebert A; Dagdemir A; Judes G; Karsli-Ceppioglu S; Daures M; Kemeny JL; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
BMC Cancer; 2014 Dec; 14():994. PubMed ID: 25535400
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic inactivation of PCDH10 in human prostate cancer cell lines.
Li Z; Li W; Xie J; Wang Y; Tang A; Li X; Ye J; Gui Y; Cai Z
Cell Biol Int; 2011 Jul; 35(7):671-6. PubMed ID: 21314642
[TBL] [Abstract][Full Text] [Related]
29. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
Kondo Y; Shen L; Cheng AS; Ahmed S; Boumber Y; Charo C; Yamochi T; Urano T; Furukawa K; Kwabi-Addo B; Gold DL; Sekido Y; Huang TH; Issa JP
Nat Genet; 2008 Jun; 40(6):741-50. PubMed ID: 18488029
[TBL] [Abstract][Full Text] [Related]
30. A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate.
Dobosy JR; Fu VX; Desotelle JA; Srinivasan R; Kenowski ML; Almassi N; Weindruch R; Svaren J; Jarrard DF
Prostate; 2008 Aug; 68(11):1187-95. PubMed ID: 18459101
[TBL] [Abstract][Full Text] [Related]
31. miR-196b Is Epigenetically Silenced during the Premalignant Stage of Lung Carcinogenesis.
Tellez CS; Juri DE; Do K; Picchi MA; Wang T; Liu G; Spira A; Belinsky SA
Cancer Res; 2016 Aug; 76(16):4741-51. PubMed ID: 27302168
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic biomarkers in prostate cancer: Current and future uses.
Chiam K; Ricciardelli C; Bianco-Miotto T
Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide DNA methylation modified by soy phytoestrogens: role for epigenetic therapeutics in prostate cancer?
Karsli-Ceppioglu S; Ngollo M; Adjakly M; Dagdemir A; Judes G; Lebert A; Boiteux JP; Penault-LLorca F; Bignon YJ; Guy L; Bernard-Gallon D
OMICS; 2015 Apr; 19(4):209-19. PubMed ID: 25831061
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
[TBL] [Abstract][Full Text] [Related]
35. Identification of radiation-induced aberrant hypomethylation in colon cancer.
Bae JH; Kim JG; Heo K; Yang K; Kim TO; Yi JM
BMC Genomics; 2015 Feb; 16(1):56. PubMed ID: 25887185
[TBL] [Abstract][Full Text] [Related]
36. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.
Lin HY; Hung SK; Lee MS; Chiou WY; Huang TT; Tseng CE; Shih LY; Lin RI; Lin JM; Lai YH; Chang CB; Hsu FC; Chen LC; Tsai SJ; Su YC; Li SC; Lai HC; Hsu WL; Liu DW; Tai CK; Wu SF; Chan MW
Oncotarget; 2015 Jan; 6(2):915-34. PubMed ID: 25460508
[TBL] [Abstract][Full Text] [Related]
37. Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.
Kamradt J; Jung V; Wahrheit K; Tolosi L; Rahnenfuehrer J; Schilling M; Walker R; Davis S; Stoeckle M; Meltzer P; Wullich B
PLoS One; 2007 Aug; 2(8):e769. PubMed ID: 17712417
[TBL] [Abstract][Full Text] [Related]
38. The pivotal role of DNA methylation in the radio-sensitivity of tumor radiotherapy.
Zhu X; Wang Y; Tan L; Fu X
Cancer Med; 2018 Aug; 7(8):3812-3819. PubMed ID: 29952116
[TBL] [Abstract][Full Text] [Related]
39. Epigenetics Reactivation of Nrf2 in Prostate TRAMP C1 Cells by Curcumin Analogue FN1.
Li W; Pung D; Su ZY; Guo Y; Zhang C; Yang AY; Zheng X; Du ZY; Zhang K; Kong AN
Chem Res Toxicol; 2016 Apr; 29(4):694-703. PubMed ID: 26991801
[TBL] [Abstract][Full Text] [Related]
40. Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells.
Bonacini M; Coletta M; Ramazzina I; Naponelli V; Modernelli A; Davalli P; Bettuzzi S; Rizzi F
Biochim Biophys Acta; 2015 Jan; 1849(1):44-54. PubMed ID: 25464035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
